Keywords
Salvarsan
Mexican press
specialized journalism
discourse
How to Cite
Citas en Dimensions Service
Abstract
Compound 606, or Salvarsan, developed by the German physician Paul Ehrlich at the beginning of the 20th century, represented a hope to end the syphilis epidemic that plagued the world at the time. For this reason, its arrival in Mexico sparked great expectations in the national press, which covered with particular interest its first applications on patients, as well as the debates that arose among the physicians who were for or against the drug. Based on these events, this article analyzes the enunciative scenes and discursive representation of patients, syphilis, and Salvarsan in the light of the texts published by several newspapers in Mexico City from 1908 to 1912, after the arrival of “Ehrlich’s great formula”.
Authors who publish in Bibliographica automatically accept the following terms:
a. Authors will keep their authorship rights and will guarantee the journal the first time publication rights of their submitted work, which will be liable to a Creative Commons license that will allow third parties to share their work as long as they give appropriate credit to the author and the first publication is attributed to Bibliographica, it is not used for commercial purposes and modified material is not distributed in case of remix, transformation or recreation.
b. Authors can adopt other non-exclusive distribution license agreements of the published version of the work (for example: deposit it in an institutional telematic archive or publish it in a monographic volume) as long as the first publication is attributed to Bibliographica.
c. Authors are encouraged to self-archive their work (for example: in institutional telematic archives or their website), for this can promote interesting exchanges and increase the citation impact of the published work. (See The effect of open access).